Since 1985, the Alzheimer’s Disease Research (ADR) program has awarded nearly $140 million to support promising research in fields ranging from molecular biology to genetics to epidemiology. ADR is currently supporting 133 outstanding biomedical researcher projects.
About Marisa de la Cruz
This author has not written his bio yet.
But we are proud to say that Marisa de la Cruz contributed 89 entries already.
Entries by Marisa de la Cruz
A small team of scientists at the Akassoglou Lab is working on what could be a big breakthrough in treating dementia and other brain diseases. To read full article , click here.
Therini Bio announced raising $17 million in a financing round to speed the development of an antibody that might treat people with inflammatory conditions, such as multiple sclerosis (MS), associated with damage to blood vessels. To read full article, click here.
Gladstone researchers harness unique tools and perspectives to pave the way to more and better treatment options for epilepsy. To read full article, click here.
The National MS Society and American Brain Foundation joined forces to support training for young clinicians committed to careers in academic medicine with an emphasis on MS clinical research. The NMSS-ABF MS Clinician-Scientist Development Award supports research for talented clinicians to address problems in MS with the most current scientific tools.
Network of Co-Expressed Proteins in Cerebrospinal Fluid from Patients with CNS Lymphoma . The American Journal of Pathology, Volume 191, Issue 3, P417-588.
Abnormal leaks in the blood-brain barrier have previously been linked to the severity of CNS lymphoma. However, the molecular details remain unclear. Now, the Akassoglou Lab has shown in mice that CNS B-cell lymphoma cells cluster at sites where there is a leak in the blood-brain barrier. They also found that a blood protein called […]
Reshmi Tognatta, PhD, received this award for Excellence in Neuroscience based on the strength and originality of her research.
Katerina Akassoglou will lead the new Gladstone-UCSF Center for Neurovascular Brain Immunology, which brings together a unique combination of expertise to enable novel therapies for Alzheimer Alzheimer’s disease and multiple sclerosis. To read full article, click here.
A generous philanthropic gift from the Simon Family Trust is supporting the creation of the new Gladstone-UCSF Center for Neurovascular Brain Immunology, which will be led by Katerina Akassoglou, PhD, senior investigator at Gladstone Institutes. The $2.5-million donation will help scientists study neurological diseases by combining basic and clinical research in vascular biology, immunology, and neuroscience. To read […]